Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Video game therapy helps kids move better at home

NCT ID NCT04510857

Symptom relief Sponsor: Barron Associates, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a virtual reality program called MOVE-IT that kids with hemiplegia (one-sided arm weakness) can use at home. 25 children participated to see if the VR exercises improve hand and arm function better than usual care. The goal was to make therapy more engaging and accessible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

25 people

The number who actually took part.

Started

Jun 2022

Finished

Jun 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 14 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of hemiplegia resulting from cerebral palsy, stroke, or other form of brain injury; * Medically stable; * Participant has antigravity strength in the affected UE at the elbow to at least 45 degrees of active flexion; * Participant has antigravity shoulder strength in the affected UE to at least 30 degrees each in active flexion, abduction/adduction, and 15 degrees in active internal/external rotation when in an upright and seated position; * Participant has ability to perform a basic color-matching test and identify characters on a vision chart; * Participant must be available to attend study visits during an approximately 3-week participation period; * Willingness and ability to comply with scheduled visits and study procedures. Exclusion Criteria: * History of uncontrolled seizures; * Has received another form of intensive UE therapy, such as CIMT, within the prior 6 months; * Unwillingness or inability to understand or follow verbal directions; * Diagnosis of moderate to severe cortical-visual impairment that in the judgement of the Principal Investigator could adversely impact the subject's participation; * Psychological diagnosis that in the determination of the Principal Investigator could significantly impact subject's participation or that could be aggravated by study participation; * Determination that participation would result in over exertion, or significant discomfort or pain; * Determination that participation would result in significant agitation or elevated stress; * Visual field deficit in either eye that impairs the ability to view the computer monitor.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemiplegia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cerebral palsy hemiplegia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Occupational therapy Virtual reality

Contacts and locations

Locations

  • Duke University

    Durham, North Carolina, 27705, United States

  • University of Virginia (UVA)

    Charlottesville, Virginia, 22908, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.